Atiomo W U, Hilton D, Fox R, Lee D, Shaw S, Friend J, Wilkin T J, Prentice A G
Department of Gynaecology, Derriford Hospital, Plymouth, UK.
Gynecol Endocrinol. 2000 Jun;14(3):162-8. doi: 10.3109/09513590009167677.
Anovulation in women with polycystic ovary syndrome (PCOS) is incompletely understood. The concentration of the glycoprotein plasminogen activator inhibitor-1 (PAI-1) is raised in insulin resistance. This has been described in the granulosa and theca cell layers of the animal but not the human ovary. This study was performed to investigate the location of PAI-1 in the human ovary and investigate whether it may contribute to anovulation in PCOS. PAI-1 was localized immunohistochemically and quantitated using computer image analysis in 17 ovarian follicles from five women with a diagnosis of PCOS and compared with 15 follicles from six normal ovaries. PAI-1 was predominantly found in the granulosa and theca cells in both polycystic and normal ovaries. Image analysis did not reveal a difference in the PAI-1 signal from polycystic compared with normal ovaries. This study shows that PAI-1 plays a role in human ovulation, but its role in PCOS requires further research.
多囊卵巢综合征(PCOS)女性的无排卵机制尚未完全明确。胰岛素抵抗时糖蛋白纤溶酶原激活物抑制剂-1(PAI-1)的浓度会升高。这在动物的颗粒细胞层和卵泡膜细胞层中已有描述,但在人类卵巢中尚未见报道。本研究旨在探究PAI-1在人类卵巢中的定位,并研究其是否可能导致PCOS患者无排卵。采用免疫组织化学方法对5例诊断为PCOS的女性的17个卵巢卵泡中的PAI-1进行定位,并使用计算机图像分析进行定量,同时与6例正常卵巢的15个卵泡进行比较。PAI-1主要存在于多囊卵巢和正常卵巢的颗粒细胞和卵泡膜细胞中。图像分析未显示多囊卵巢与正常卵巢的PAI-1信号存在差异。本研究表明,PAI-1在人类排卵中起作用,但其在PCOS中的作用仍需进一步研究。